# CNS Pharmaceuticals, Inc. — Form D

CNS Pharmaceuticals, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-19. The offering totals $22.5M, of which $22.5M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2026-05-19
- Form: D
- Accession: 0001683168-26-004126
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $22.5M
- Amount sold: $22.5M
- Investors: 13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-584551

## Issuer

- Name: CNS Pharmaceuticals, Inc.
- CIK: 0001729427
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 2100 WEST LOOP SOUTH SUITE 900, HOUSTON, TX, 77027
- Phone: 800-946-9185

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Faith Charles | Related Person | Houston, TX |
| Bettina Cockroft | Related Person | Houston, TX |
| Michal Fisher | Related Person | Houston, TX |
| Jeffry Keyes | Related Person | Houston, TX |
| Rami Levin | Related Person | Houston, TX |
| Amy Mahery | Related Person | Houston, TX |
| STEVE O'LOUGHLIN | Related Person | Houston, TX |

## More

- [CIK 1729427 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1729427&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001683168-26-004126.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.